Overdiagnosis and overtreatment of prostate cancer

S Loeb, MA Bjurlin, J Nicholson, TL Tammela… - European urology, 2014 - Elsevier
Abstract Context Although prostate cancer (PCa) screening reduces the incidence of
advanced disease and mortality, trade-offs include overdiagnosis and resultant …

Standards for prostate biopsy

MA Bjurlin, SS Taneja - Current opinion in urology, 2014 - journals.lww.com
A 12-core systematic biopsy that incorporates apical and far-lateral cores in the template
distribution allows maximal cancer detection, avoidance of a repeat biopsy while minimizing …

Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging–guided biopsies versus a systematic 10-core …

T Hambrock, C Hoeks, C Hulsbergen-Van De Kaa… - European urology, 2012 - Elsevier
BACKGROUND: Accurate pretreatment assessment of prostate cancer (PCa)
aggressiveness is important in decision making. Gleason grade is a critical predictor of the …

PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study

MC Gittelman, B Hertzman, J Bailen, T Williams… - The Journal of …, 2013 - Elsevier
PURPOSE: We evaluated the clinical usefulness of the PROGENSA® PCA3 Assay for
predicting repeat prostate biopsy outcome. MATERIALS AND METHODS: Men with at least …

MR safe robot, FDA clearance, safety and feasibility of prostate biopsy clinical trial

D Stoianovici, C Kim, D Petrisor, C Jun… - IEEE/ASME …, 2016 - ieeexplore.ieee.org
Compatibility of mechatronic devices with the MR environment has been a very challenging
engineering task. After over a decade of developments, we report the successful translation …

A novel phage display based platform for exosome diversity characterization

D Maisano, S Mimmi, V Dattilo, F Marino, M Gentile… - Nanoscale, 2022 - pubs.rsc.org
We present an innovative approach allowing the identification, isolation, and molecular
characterization of disease-related exosomes based on their different antigenic reactivities …

Patterns of repeat prostate biopsy in contemporary clinical practice

NE Abraham, N Mendhiratta, SS Taneja - The Journal of urology, 2015 - auajournals.org
Purpose: The objectives of this study were to 1) describe the patterns of repeat prostate
biopsy in men with a previous negative biopsy and 2) identify predictors of prostate cancer …

[HTML][HTML] Reduced rate of repeated prostate biopsies observed in ConfirmMDx clinical utility field study

KJ Wojno, FJ Costa, RJ Cornell, JD Small… - American health & …, 2014 - ncbi.nlm.nih.gov
Background The diagnosis of prostate cancer is dependent on histologic confirmation in
biopsy core tissues. The biopsy procedure is invasive, puts the patient at risk for …

[HTML][HTML] Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men

RL Waterhouse Jr, L Van Neste, KA Moses… - Urology, 2019 - Elsevier
Objective To evaluate an epigenetic assay performed on tissue from negative prostate
biopsies in a group of African American (AA) men undergoing repeat biopsy, and to …

[HTML][HTML] Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending

W Aubry, R Lieberthal, A Willis, G Bagley… - American health & …, 2013 - ncbi.nlm.nih.gov
Background The diagnosis of prostate cancer involves invasive, sometimes harmful,
procedures that can entail negative quality-of-life implications to individuals and high …